Diamonds and Dogs
7/23/14Puma Biotechnology Inc. (PBYI)
Puma Biotechnology exploded today up 219.82% to $230.51 after a previous close of $59.03. The biotech company saw its shares more than triple after their breast cancer drug neratinib passed its trial's goals in a stage 3 trial. The scenario for Puma and its shareholders was one of the best cases they could have hoped for. The trials for other combinations of neratinib indicate that there may just be more room for the stock to run in the future for Puma.
Tupperware Brands Corp. (TUP)
Tupperware Brands Corporation experienced a dip in today's market, down 10.29% to $76 a share. The American multinational direct sales company headquartered in Orlando, Florida lowered its full year guidance following second quarter postings that were lower than expected. TUP's quarterly profits fell 38% to $47.6 million $1.43 per diluted share while analysts were expecting earnings of $1.47 per share. Analysts still rate the stock as a buy despite today's drop because the strengths of the company will continue to out-weigh the weaknesses.